Product Code: PMRREP32516
CMO/CDMO Biotechnology Market: Scope of the Report
The latest publication by Persistence Market Research on the global CMO/CDMO biotechnology market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for CMO/CDMO biotechnology services and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the CMO/CDMO biotechnology market. Shareholders in the CMO/CDMO biotechnology market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the CMO/CDMO biotechnology market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research's study on the CMO/CDMO biotechnology market offers information divided into six important segments - service, product, expression systems, company size, scale of operation, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Service
Stand-Alone Services
Cell Line Development
Development and Bio Manufacturing
Analytical Services
Fill finish
Packaging
Clinical Supply Services
Integrated
Product
Monoclonal Antibodies
Antibody Fragments
Recombinant Therapeutic Proteins
Viral Vector
Cell and Gene Therapy
Vaccine
Expression System
Mammalian
Microbial
Bacteria
Yeast
Company Size
Small
Mid-sized
Large
Very large
Scale of Operations
Preclinical
Clinical
Commercial
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Key Questions Answered in Report:
Which regions will continue to remain the most profitable markets for CMO/CDMO biotechnology over the coming years?
How will changing trends influence the market?
How has the COVID-19 crisis influenced market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the CMO/CDMO biotechnology market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the CMO/CDMO biotechnology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research's projections on the growth prospects of the CMO/CDMO biotechnology market are more accurate and reliable.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supply Side Trends
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 2.3. Inclusions and Exclusions
3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Innovation / Development Trends
4. Key Success Factors
- 4.1. Service Adoption Analysis
- 4.2. Key Regulations
- 4.3. Key promotional Strategies, By Key Players
- 4.4. PESTEL Analysis
- 4.5. Service Pricing Analysis
5. Market Background
- 5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Global CMO/CDMO Market Outlook
- 5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increase in R&D Spending
- 5.2.2. Growing Lifestyle Disease Prevalence
- 5.2.3. Cost of Services
- 5.2.4. Service Adoption Rate
- 5.2.5. Advancements in Technology
- 5.2.6. Changes in Regulatory Policies
- 5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
- 6.1. COVID-19 and Impact Analysis
- 6.1.1. By Services
- 6.1.2. By Product
- 6.1.3. By Expression Systems
- 6.1.4. By Company Size
- 6.1.5. By Scale of Operations
- 6.1.6. By Country
- 6.2. 2022 Market Scenario
7. Global CMO/CDMO Biotechnology Market Demand (in Value or Size in US$ Mn) Analysis 2016-2022 and Forecast, 2023-2033
- 7.1. Historical Market Value (US$ Mn) Analysis, 2016-2022
- 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
8. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Services
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis By Services, 2016-2022
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Services, 2023-2033
- 8.3.1. Stand-Alone Services
- 8.3.1.1. Cell Line Development
- 8.3.1.2. Development and Bio Manufacturing
- 8.3.1.3. Analytical Services
- 8.3.1.4. Fill finish
- 8.3.1.5. Packaging
- 8.3.1.6. Clinical Supply Services
- 8.3.2. Integrated
- 8.4. Market Attractiveness Analysis By Services
9. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Product
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Mn) Analysis, By Product, 2016-2022
- 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2023-2033
- 9.3.1. Monoclonal Antibodies
- 9.3.2. Antibody Fragments
- 9.3.3. Recombinant Therapeutic Proteins
- 9.3.4. Viral Vector
- 9.3.5. Cell and Gene Therapy
- 9.3.6. Vaccine
- 9.4. Market Attractiveness Analysis By Product
10. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Expression Systems
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Mn) Analysis, By Expression Systems, 2016-2022
- 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Expression Systems, 2023-2033
- 10.3.1. Mammalian
- 10.3.2. Microbial
- 10.3.2.1. Bacteria
- 10.3.2.2. Yeast
- 10.4. Market Attractiveness Analysis By Expression Systems
11. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Company Size
- 11.1. Introduction / Key Findings
- 11.2. Historical Market Size (US$ Mn) Analysis, By Company Size, 2016-2022
- 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Company Size, 2023-2033
- 11.3.1. Small
- 11.3.2. Mid-sized
- 11.3.3. Large
- 11.3.4. Very large
- 11.4. Market Attractiveness Analysis By Company Size
12. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Scale of Operation
- 12.1. Introduction / Key Findings
- 12.2. Historical Market Size (US$ Mn) Analysis, By Scale of Operation, 2016-2022
- 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Scale of Operation, 2023-2033
- 12.3.1. Preclinical
- 12.3.2. Clinical
- 12.3.3. Commercial
- 12.4. Market Attractiveness Analysis By Scale of Operation
13. Global CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033, By Region
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2022
- 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
- 13.3.1. North America
- 13.3.2. Latin America
- 13.3.3. Europe
- 13.3.4. East Asia
- 13.3.5. South Asia
- 13.3.6. Oceania
- 13.3.7. Middle East and Africa (MEA)
- 13.4. Market Attractiveness Analysis By Region
14. North America CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
- 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 14.3.1. By Country
- 14.3.1.1. U.S.
- 14.3.1.2. Canada
- 14.3.2. By Services
- 14.3.3. By Product
- 14.3.4. By Expression Systems
- 14.3.5. By Company Size
- 14.3.6. By Scale of Operation
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Services
- 14.4.3. By Product
- 14.4.4. By Expression Systems
- 14.4.5. By Company Size
- 14.4.6. By Scale of Operation
- 14.5. Market Trends
- 14.6. Drivers and Restraints - Impact Analysis
- 14.7. Key Players - Intensity Mapping
- 14.8. Country Level Analysis & Forecast
- 14.8.1. U.S. CMO/CDMO Biotechnology Market Analysis
- 14.8.1.1. Introduction
- 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.1.2.1. By Services
- 14.8.1.2.2. By Product
- 14.8.1.2.3. By Expression Systems
- 14.8.1.2.4. By Company Size
- 14.8.1.2.5. By Scale of Operation
- 14.8.2. Canada CMO/CDMO Biotechnology Market Analysis
- 14.8.2.1. Introduction
- 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.2.2.1. By Services
- 14.8.2.2.2. By Product
- 14.8.2.2.3. By Expression Systems
- 14.8.2.2.4. By Company Size
- 14.8.2.2.5. By Scale of Operation
15. Latin America CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
- 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 15.3.1. By Country
- 15.3.1.1. Mexico
- 15.3.1.2. Brazil
- 15.3.1.3. Argentina
- 15.3.1.4. Rest of Latin America
- 15.3.2. By Services
- 15.3.3. By Product
- 15.3.4. By Expression Systems
- 15.3.5. By Company Size
- 15.3.6. By Scale of Operation
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Services
- 15.4.3. By Product
- 15.4.4. By Expression Systems
- 15.4.5. By Company Size
- 15.4.6. By Scale of Operation
- 15.5. Market Trends
- 15.6. Drivers and Restraints - Impact Analysis
- 15.7. Key Players - Intensity Mapping
- 15.8. Country Level Analysis & Forecast
- 15.8.1. Mexico CMO/CDMO Biotechnology Market Analysis
- 15.8.1.1. Introduction
- 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.1.2.1. By Services
- 15.8.1.2.2. By Product
- 15.8.1.2.3. By Expression Systems
- 15.8.1.2.4. By Company Size
- 15.8.1.2.5. By Scale of Operation
- 15.8.2. Brazil CMO/CDMO Biotechnology Market Analysis
- 15.8.2.1. Introduction
- 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.2.2.1. By Services
- 15.8.2.2.2. By Product
- 15.8.2.2.3. By Expression Systems
- 15.8.2.2.4. By Company Size
- 15.8.2.2.5. By Scale of Operation
- 15.8.3. Argentina CMO/CDMO Biotechnology Market Analysis
- 15.8.3.1. Introduction
- 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.3.2.1. By Services
- 15.8.3.2.2. By Product
- 15.8.3.2.3. By Expression Systems
- 15.8.3.2.4. By Company Size
- 15.8.3.2.5. By Scale of Operation
16. Europe CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
- 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 16.3.1. By Country
- 16.3.1.1. Germany
- 16.3.1.2. Italy
- 16.3.1.3. France
- 16.3.1.4. U.K.
- 16.3.1.5. Spain
- 16.3.1.6. BENELUX
- 16.3.1.7. Russia
- 16.3.1.8. Rest of Europe
- 16.3.2. By Services
- 16.3.3. By Product
- 16.3.4. By Expression Systems
- 16.3.5. By Company Size
- 16.3.6. By Scale of Operation
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Services
- 16.4.3. By Product
- 16.4.4. By Expression Systems
- 16.4.5. By Company Size
- 16.4.6. By Scale of Operation
- 16.5. Market Trends
- 16.6. Drivers and Restraints - Impact Analysis
- 16.7. Key Players - Intensity Mapping
- 16.8. Country Level Analysis & Forecast
- 16.8.1. Germany CMO/CDMO Biotechnology Market Analysis
- 16.8.1.1. Introduction
- 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.1.2.1. By Services
- 16.8.1.2.2. By Product
- 16.8.1.2.3. By Expression Systems
- 16.8.1.2.4. By Company Size
- 16.8.1.2.5. By Scale of Operation
- 16.8.2. Italy CMO/CDMO Biotechnology Market Analysis
- 16.8.2.1. Introduction
- 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.2.2.1. By Services
- 16.8.2.2.2. By Product
- 16.8.2.2.3. By Expression Systems
- 16.8.2.2.4. By Company Size
- 16.8.2.2.5. By Scale of Operation
- 16.8.3. France CMO/CDMO Biotechnology Market Analysis
- 16.8.3.1. Introduction
- 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.3.2.1. By Services
- 16.8.3.2.2. By Product
- 16.8.3.2.3. By Expression Systems
- 16.8.3.2.4. By Company Size
- 16.8.3.2.5. By Scale of Operation
- 16.8.4. U.K. CMO/CDMO Biotechnology Market Analysis
- 16.8.4.1. Introduction
- 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.4.2.1. By Services
- 16.8.4.2.2. By Product
- 16.8.4.2.3. By Expression Systems
- 16.8.4.2.4. By Company Size
- 16.8.4.2.5. By Scale of Operation
- 16.8.5. Spain CMO/CDMO Biotechnology Market Analysis
- 16.8.5.1. Introduction
- 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.5.2.1. By Services
- 16.8.5.2.2. By Product
- 16.8.5.2.3. By Expression Systems
- 16.8.5.2.4. By Company Size
- 16.8.5.2.5. By Scale of Operation
- 16.8.6. BENELUX CMO/CDMO Biotechnology Market Analysis
- 16.8.6.1. Introduction
- 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.6.2.1. By Services
- 16.8.6.2.2. By Product
- 16.8.6.2.3. By Expression Systems
- 16.8.6.2.4. By Company Size
- 16.8.6.2.5. By Scale of Operation
- 16.8.7. Russia CMO/CDMO Biotechnology Market Analysis
- 16.8.7.1. Introduction
- 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.7.2.1. By Services
- 16.8.7.2.2. By Product
- 16.8.7.2.3. By Expression Systems
- 16.8.7.2.4. By Company Size
- 16.8.7.2.5. By Scale of Operation
17. East Asia CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
- 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 17.3.1. By Country
- 17.3.1.1. China
- 17.3.1.2. Japan
- 17.3.1.3. South Korea
- 17.3.2. By Services
- 17.3.3. By Product
- 17.3.4. By Expression Systems
- 17.3.5. By Company Size
- 17.3.6. By Scale of Operation
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Services
- 17.4.3. By Product
- 17.4.4. By Expression Systems
- 17.4.5. By Company Size
- 17.4.6. By Scale of Operation
- 17.5. Market Trends
- 17.6. Drivers and Restraints - Impact Analysis
- 17.7. Key Players - Intensity Mapping
- 17.8. Country Level Analysis & Forecast
- 17.8.1. China CMO/CDMO Biotechnology Market Analysis
- 17.8.1.1. Introduction
- 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.1.2.1. By Services
- 17.8.1.2.2. By Product
- 17.8.1.2.3. By Expression Systems
- 17.8.1.2.4. By Company Size
- 17.8.1.2.5. By Scale of Operation
- 17.8.2. Japan CMO/CDMO Biotechnology Market Analysis
- 17.8.2.1. Introduction
- 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.2.2.1. By Services
- 17.8.2.2.2. By Product
- 17.8.2.2.3. By Expression Systems
- 17.8.2.2.4. By Company Size
- 17.8.2.2.5. By Scale of Operation
- 17.8.3. South Korea CMO/CDMO Biotechnology Market Analysis
- 17.8.3.1. Introduction
- 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.3.2.1. By Services
- 17.8.3.2.2. By Product
- 17.8.3.2.3. By Expression Systems
- 17.8.3.2.4. By Company Size
- 17.8.3.2.5. By Scale of Operation
18. South Asia CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033
- 18.1. Introduction
- 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
- 18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 18.3.1. By Country
- 18.3.1.1. India
- 18.3.1.2. Indonesia
- 18.3.1.3. Malaysia
- 18.3.1.4. Thailand
- 18.3.1.5. Rest of South Asia
- 18.3.2. By Services
- 18.3.3. By Product
- 18.3.4. By Expression Systems
- 18.3.5. By Company Size
- 18.3.6. By Scale of Operation
- 18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Services
- 18.4.3. By Product
- 18.4.4. By Expression Systems
- 18.4.5. By Company Size
- 18.4.6. By Scale of Operation
- 18.5. Market Trends
- 18.6. Drivers and Restraints - Impact Analysis
- 18.7. Key Players - Intensity Mapping
- 18.8. Country Level Analysis & Forecast
- 18.8.1. India CMO/CDMO Biotechnology Market Analysis
- 18.8.1.1. Introduction
- 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.1.2.1. By Services
- 18.8.1.2.2. By Product
- 18.8.1.2.3. By Expression Systems
- 18.8.1.2.4. By Company Size
- 18.8.1.2.5. By Scale of Operation
- 18.8.2. Indonesia CMO/CDMO Biotechnology Market Analysis
- 18.8.2.1. Introduction
- 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.2.2.1. By Services
- 18.8.2.2.2. By Product
- 18.8.2.2.3. By Expression Systems
- 18.8.2.2.4. By Company Size
- 18.8.2.2.5. By Scale of Operation
- 18.8.3. Malaysia CMO/CDMO Biotechnology Market Analysis
- 18.8.3.1. Introduction
- 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.3.2.1. By Services
- 18.8.3.2.2. By Product
- 18.8.3.2.3. By Expression Systems
- 18.8.3.2.4. By Company Size
- 18.8.3.2.5. By Scale of Operation
- 18.8.4. Thailand CMO/CDMO Biotechnology Market Analysis
- 18.8.4.1. Introduction
- 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.4.2.1. By Services
- 18.8.4.2.2. By Product
- 18.8.4.2.3. By Expression Systems
- 18.8.4.2.4. By Company Size
- 18.8.4.2.5. By Scale of Operation
19. Oceania CMO/CDMO Biotechnology Market 2016-2022 and Forecast 2023-2033
- 19.1. Introduction
- 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
- 19.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 19.3.1. By Country
- 19.3.1.1. Australia
- 19.3.1.2. New Zealand
- 19.3.2. By Services
- 19.3.3. By Product
- 19.3.1. By Expression Systems
- 19.3.2. By Company Size
- 19.3.3. By Scale of Operation
- 19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Services
- 19.4.3. By Product
- 19.4.4. By Expression Systems
- 19.4.5. By Company Size
- 19.4.6. By Scale of Operation
- 19.5. Market Trends
- 19.6. Drivers and Restraints - Impact Analysis
- 19.7. Key Players - Intensity Mapping
- 19.8. Country Level Analysis & Forecast
- 19.8.1. Australia CMO/CDMO Biotechnology Market Analysis
- 19.8.1.1. Introduction
- 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 19.8.1.2.1. By Services
- 19.8.1.2.2. By Product
- 19.8.1.2.3. By Expression Systems
- 19.8.1.2.4. By Company Size
- 19.8.1.2.5. By Scale of Operation
- 19.8.2. New Zealand CMO/CDMO Biotechnology Market Analysis
- 19.8.2.1. Introduction
- 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 19.8.2.2.1. By Services
- 19.8.2.2.2. By Product
- 19.8.2.2.3. By Expression Systems
- 19.8.2.2.4. By Company Size
- 19.8.2.2.5. By Scale of Operation
20. Middle East and Africa (MEA) CMO/CDMO Biotechnology Market Analysis 2016-2022 and Forecast 2023-2033
- 20.1. Introduction
- 20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
- 20.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
- 20.3.1. By Country
- 20.3.1.1. GCC Countries
- 20.3.1.2. Turkey
- 20.3.1.3. North Africa
- 20.3.1.4. South Africa
- 20.3.1.5. Rest of Middle East and Africa
- 20.3.2. By Services
- 20.3.3. By Product
- 20.3.4. By Expression Systems
- 20.3.5. By Company Size
- 20.3.6. By Scale of Operation
- 20.4. Market Attractiveness Analysis
- 20.4.1. By Country
- 20.4.2. By Services
- 20.4.3. By Product
- 20.4.4. By Expression Systems
- 20.4.5. By Company Size
- 20.4.6. By Scale of Operation
- 20.5. Market Trends
- 20.6. Drivers and Restraints - Impact Analysis
- 20.7. Key Players - Intensity Mapping
- 20.8. Country Level Analysis & Forecast
- 20.8.1. GCC Countries CMO/CDMO Biotechnology Market Analysis
- 20.8.1.1. Introduction
- 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 20.8.1.2.1. By Services
- 20.8.1.2.2. By Product
- 20.8.1.2.3. By Expression Systems
- 20.8.1.2.4. By Company Size
- 20.8.1.2.5. By Scale of Operation
- 20.8.2. Turkey CMO/CDMO Biotechnology Market Analysis
- 20.8.2.1. Introduction
- 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 20.8.2.2.1. By Services
- 20.8.2.2.2. By Product
- 20.8.2.2.3. By Expression Systems
- 20.8.2.2.4. By Company Size
- 20.8.2.2.5. By Scale of Operation
- 20.8.3. South Africa CMO/CDMO Biotechnology Market Analysis
- 20.8.3.1. Introduction
- 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 20.8.3.2.1. By Services
- 20.8.3.2.2. By Product
- 20.8.3.2.3. By Expression Systems
- 20.8.3.2.4. By Company Size
- 20.8.3.2.5. By Scale of Operation
- 20.8.4. North Africa CMO/CDMO Biotechnology Market Analysis
- 20.8.4.1. Introduction
- 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 20.8.4.2.1. By Services
- 20.8.4.2.2. By Product
- 20.8.4.2.3. By Expression Systems
- 20.8.4.2.4. By Company Size
- 20.8.4.2.5. By Scale of Operation
21. Market Structure Analysis
- 21.1. Market Analysis by Tier of Companies
- 21.2. Market Share Analysis of Top Players
- 21.3. Market Presence Analysis
22. Competition Analysis
- 22.1. Competition Dashboard
- 22.2. Competition Deep Dive
- 22.2.1. Patheon N.V.
- 22.2.1.1. Overview
- 22.2.1.2. Service/Product Portfolio
- 22.2.1.3. Sales Footprint
- 22.2.1.4. Key Financials
- 22.2.1.5. SWOT Analysis
- 22.2.1.6. Strategy Overview
- 22.2.1.6.1. Marketing Strategy
- 22.2.1.6.2. Service Strategy
- 22.2.1.6.3. Channel Strategy
- 22.2.2. Catalent
- 22.2.2.1. Overview
- 22.2.2.2. Service/Product Portfolio
- 22.2.2.3. Sales Footprint
- 22.2.2.4. Key Financials
- 22.2.2.5. SWOT Analysis
- 22.2.2.6. Strategy Overview
- 22.2.2.6.1. Marketing Strategy
- 22.2.2.6.2. Service Strategy
- 22.2.2.6.3. Channel Strategy
- 22.2.3. Samsung Biologics Co., Ltd
- 22.2.3.1. Overview
- 22.2.3.2. Service/Product Portfolio
- 22.2.3.3. Sales Footprint
- 22.2.3.4. Key Financials
- 22.2.3.5. SWOT Analysis
- 22.2.3.6. Strategy Overview
- 22.2.3.6.1. Marketing Strategy
- 22.2.3.6.2. Service Strategy
- 22.2.3.6.3. Channel Strategy
- 22.2.4. Lonza.
- 22.2.4.1. Overview
- 22.2.4.2. Service/Product Portfolio
- 22.2.4.3. Sales Footprint
- 22.2.4.4. Key Financials
- 22.2.4.5. SWOT Analysis
- 22.2.4.6. Strategy Overview
- 22.2.4.6.1. Marketing Strategy
- 22.2.4.6.2. Service Strategy
- 22.2.4.6.3. Channel Strategy
- 22.2.5. Boehringer Ingelheim
- 22.2.5.1. Overview
- 22.2.5.2. Service/Product Portfolio
- 22.2.5.3. Sales Footprint
- 22.2.5.4. Key Financials
- 22.2.5.5. SWOT Analysis
- 22.2.5.6. Strategy Overview
- 22.2.5.6.1. Marketing Strategy
- 22.2.5.6.2. Service Strategy
- 22.2.5.6.3. Channel Strategy
- 22.2.6. Samsung BioLogics
- 22.2.6.1. Overview
- 22.2.6.2. Service/Product Portfolio
- 22.2.6.3. Sales Footprint
- 22.2.6.4. Key Financials
- 22.2.6.5. SWOT Analysis
- 22.2.6.6. Strategy Overview
- 22.2.6.6.1. Marketing Strategy
- 22.2.6.6.2. Service Strategy
- 22.2.6.6.3. Channel Strategy
- 22.2.7. AGC Biologics, Inc.
- 22.2.7.1. Overview
- 22.2.7.2. Service/Product Portfolio
- 22.2.7.3. Sales Footprint
- 22.2.7.4. Key Financials
- 22.2.7.5. SWOT Analysis
- 22.2.7.6. Strategy Overview
- 22.2.7.6.1. Marketing Strategy
- 22.2.7.6.2. Service Strategy
- 22.2.7.6.3. Channel Strategy
- 22.2.8. WuXi Biologics
- 22.2.8.1. Overview
- 22.2.8.2. Service/Product Portfolio
- 22.2.8.3. Sales Footprint
- 22.2.8.4. Key Financials
- 22.2.8.5. SWOT Analysis
- 22.2.8.6. Strategy Overview
- 22.2.8.6.1. Marketing Strategy
- 22.2.8.6.2. Service Strategy
- 22.2.8.6.3. Channel Strategy
- 22.2.9. AbbVie Inc
- 22.2.9.1. Overview
- 22.2.9.2. Service/Product Portfolio
- 22.2.9.3. Sales Footprint
- 22.2.9.4. Key Financials
- 22.2.9.5. SWOT Analysis
- 22.2.9.6. Strategy Overview
- 22.2.9.6.1. Marketing Strategy
- 22.2.9.6.2. Service Strategy
- 22.2.9.6.3. Channel Strategy
- 22.2.10. Avid Bioservices, Inc.
- 22.2.10.1. Overview
- 22.2.10.2. Service/Product Portfolio
- 22.2.10.3. Sales Footprint
- 22.2.10.4. Key Financials
- 22.2.10.5. SWOT Analysis
- 22.2.10.6. Strategy Overview
- 22.2.10.6.1. Marketing Strategy
- 22.2.10.6.2. Service Strategy
- 22.2.10.6.3. Channel Strategy
- 22.2.11. Fujifilm Diosynth Biotechnologies
- 22.2.11.1. Overview
- 22.2.11.2. Service/Product Portfolio
- 22.2.11.3. Sales Footprint
- 22.2.11.4. Key Financials
- 22.2.11.5. SWOT Analysis
- 22.2.11.6. Strategy Overview
- 22.2.11.6.1. Marketing Strategy
- 22.2.11.6.2. Service Strategy
- 22.2.11.6.3. Channel Strategy
- 22.2.12. Xpress Biologic
- 22.2.12.1. Overview
- 22.2.12.2. Service/Product Portfolio
- 22.2.12.3. Sales Footprint
- 22.2.12.4. Key Financials
- 22.2.12.5. SWOT Analysis
- 22.2.12.6. Strategy Overview
- 22.2.12.6.1. Marketing Strategy
- 22.2.12.6.2. Service Strategy
- 22.2.12.6.3. Channel Strategy
- 22.2.13. Rentschler Biopharma SE
- 22.2.13.1. Overview
- 22.2.13.2. Service/Product Portfolio
- 22.2.13.3. Sales Footprint
- 22.2.13.4. Key Financials
- 22.2.13.5. SWOT Analysis
- 22.2.13.6. Strategy Overview
- 22.2.13.6.1. Marketing Strategy
- 22.2.13.6.2. Service Strategy
- 22.2.13.6.3. Channel Strategy
- 22.2.14. KBI Biopharma (JSR Corporation)
- 22.2.14.1. Overview
- 22.2.14.2. Service/Product Portfolio
- 22.2.14.3. Sales Footprint
- 22.2.14.4. Key Financials
- 22.2.14.5. SWOT Analysis
- 22.2.14.6. Strategy Overview
- 22.2.14.6.1. Marketing Strategy
- 22.2.14.6.2. Service Strategy
- 22.2.14.6.3. Channel Strategy
- 22.2.15. Cytovance Biologics
- 22.2.15.1. Overview
- 22.2.15.2. Service/Product Portfolio
- 22.2.15.3. Sales Footprint
- 22.2.15.4. Key Financials
- 22.2.15.5. SWOT Analysis
- 22.2.15.6. Strategy Overview
- 22.2.15.6.1. Marketing Strategy
- 22.2.15.6.2. Service Strategy
- 22.2.15.6.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology